Lv1
54 积分 2024-02-27 加入
POS0702 TREATMENT EFFICACY AND SAFETY OF ADALIMUMAB VERSUS TOCILIZUMAB COMBINED WITH METHOTREXATE AND GLUCOCORTICOIDS IN PATIENTS WITH ACTIVE AND SEVERE TAKAYASU ARTERITIS: A RANDOMIZED, OPEN-LABEL, HEAD-TO-HEAD STUDY
6天前
已完结
CAR T-cell therapy in SLE: A systematic review
18天前
已完结
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
18天前
已完结
DeepDegradome: A structure-aware deep learning framework for PROTAC and ligand generation against protein targets
1个月前
已完结
B lymphocyte protein factories produced by hematopoietic stem cell gene editing
1个月前
已完结
Prime Editing for p47 phox -Deficient Chronic Granulomatous Disease
1个月前
已完结
GLP-1R–GIPR–PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice
1个月前
已完结
Lentiviral gene therapy for X-linked chronic granulomatous disease
1个月前
已完结
A Randomized Controlled Clinical Trial of the Serotonin Type 3 Receptor Antagonist Alosetron in Women With Diarrhea-Predominant Irritable Bowel Syndrome
2个月前
已完结
Analysis of phase II and phase III clinical trial terminations from 2013 to 2023
2个月前
已完结
皖公网安备34019202002308
